TP53 TUMOR SUPPRESSOR GENE - A MODEL FOR INVESTIGATING HUMAN MUTAGENESIS

被引:0
|
作者
DEFROMENTEL, CC
SOUSSI, T
机构
[1] UNIV PARIS 06, CTR GENET MOLEC, INSERM, U301, 27 RUE J DODU, F-75010 PARIS, FRANCE
[2] UNITE ONCOL MOLEC, UPR 275, VILLEJUIF, FRANCE
来源
GENES CHROMOSOMES & CANCER | 1992年 / 4卷 / 01期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
More than 350 independent point mutations of the TP53 gene, found in a wide variety of human cancers, were compiled and analysed. From this study, we confirm the presence of four hot-spot regions which colocalize with some highly conserved domains of the protein. We also define a new hot-spot region which is observed predominantly in lung tumors. Analysis of the mutational events suggests the direct involvement of environmental carcinogens in lung tumors and hepatocarcinomas, and spontaneous mutagenesis generating essentially CpG transitions in most of the remaining ones. Furthermore, we demonstrate in this work that the TP53 gene is an informative model with which to study the molecular mechanisms of mutagenesis in the human genome.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 50 条
  • [41] TP53 status and gene amplification in human colorectal carcinomas
    Soulié, P
    Fourme, E
    Hamelin, R
    Asselain, B
    Salmon, RJ
    Dutrillaux, B
    Muleris, M
    CANCER GENETICS AND CYTOGENETICS, 1999, 115 (02) : 118 - 122
  • [42] Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation
    Houldsworth, J
    Xiao, H
    Murty, VVVS
    Chen, WY
    Ray, B
    Reuter, VE
    Bosl, GJ
    Chaganti, RSK
    ONCOGENE, 1998, 16 (18) : 2345 - 2349
  • [43] Why are there hotspot mutations in the TP53 gene in human cancers?
    Evan H Baugh
    Hua Ke
    Arnold J Levine
    Richard A Bonneau
    Chang S Chan
    Cell Death & Differentiation, 2018, 25 : 154 - 160
  • [44] DETECTION OF TP53 GENE-MUTATIONS IN HUMAN SARCOMAS
    CASTRESANA, JS
    RUBIO, MP
    GOMEZ, L
    KREICBERGS, A
    ZETTERBERG, A
    BARRIOS, C
    EUROPEAN JOURNAL OF CANCER, 1995, 31A (05) : 735 - 738
  • [45] Low-dose-rate radiation attenuates the response of the tumor suppressor TP53
    Ohnishi, T
    Wang, XJ
    Takahashi, A
    Ohnishi, K
    Ejima, Y
    RADIATION RESEARCH, 1999, 151 (03) : 368 - 372
  • [46] Body mass index (BMI) and mutations of tumor suppressor gene p53 (TP53) in patients with urinary bladder cancer
    Ecke, Thorsten H.
    Schlechte, Horst H.
    Gunia, Sven
    Lenk, Severin V.
    Loening, Stefan A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2008, 26 (05) : 470 - 473
  • [47] Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation
    Jane Houldsworth
    Han Xiao
    VVVS Murty
    Weiyi Chen
    Beevash Ray
    Victor E Reuter
    George J Bosl
    RSK Chaganti
    Oncogene, 1998, 16 : 2345 - 2349
  • [48] Analysis of polymorphisms at the tumor suppressor gene p53 (TP53) in contributing to the risk for schizophrenia and its associated neurocognitive deficits
    Papiol, S
    Arias, B
    Barrantes-Vidal, N
    Guitart, M
    Salgado, P
    Catalán, R
    Fañanás, L
    NEUROSCIENCE LETTERS, 2004, 363 (01) : 78 - 80
  • [49] The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53
    Szczepny, Anette
    Carey, Kirstyn
    McKenzie, Lisa
    Jayasekara, W. Samantha N.
    Rossello, Fernando
    Gonzalez-Rajal, Alvaro
    Mccaw, Andrew S.
    Popovski, Dean
    Wang, Die
    Sadler, Anthony J.
    Mahar, Annabelle
    Russell, Prudence A.
    Wright, Gavin
    McCloy, Rachael A.
    Garama, Daniel J.
    Gough, Daniel J.
    Baylin, Stephen B.
    Burgess, Andrew
    Cain, Jason E.
    Watkins, D. Neil
    ONCOGENE, 2018, 37 (14) : 1939 - 1948
  • [50] The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53
    Anette Szczepny
    Kirstyn Carey
    Lisa McKenzie
    W. Samantha N. Jayasekara
    Fernando Rossello
    Alvaro Gonzalez-Rajal
    Andrew S. McCaw
    Dean Popovski
    Die Wang
    Anthony J. Sadler
    Annabelle Mahar
    Prudence A. Russell
    Gavin Wright
    Rachael A. McCloy
    Daniel J. Garama
    Daniel J. Gough
    Stephen B. Baylin
    Andrew Burgess
    Jason E. Cain
    D. Neil Watkins
    Oncogene, 2018, 37 : 1939 - 1948